questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines de transport
Protéines AAA
Protéines AAA : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéines AAA : Questions médicales les plus fréquentes",
"headline": "Protéines AAA : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéines AAA : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-24",
"dateModified": "2025-05-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéines AAA"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines de transport",
"url": "https://questionsmedicales.fr/mesh/D002352",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de transport",
"code": {
"@type": "MedicalCode",
"code": "D002352",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "ATPases associated with diverse cellular activities",
"alternateName": "ATPases Associated with Diverse Cellular Activities",
"url": "https://questionsmedicales.fr/mesh/D000074183",
"about": {
"@type": "MedicalCondition",
"name": "ATPases associated with diverse cellular activities",
"code": {
"@type": "MedicalCode",
"code": "D000074183",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "ATP-dependent proteases",
"alternateName": "ATP-Dependent Proteases",
"url": "https://questionsmedicales.fr/mesh/D049069",
"about": {
"@type": "MedicalCondition",
"name": "ATP-dependent proteases",
"code": {
"@type": "MedicalCode",
"code": "D049069",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750.032"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "ATP-dependent endopeptidases",
"alternateName": "ATP-Dependent Endopeptidases",
"url": "https://questionsmedicales.fr/mesh/D057065",
"about": {
"@type": "MedicalCondition",
"name": "ATP-dependent endopeptidases",
"code": {
"@type": "MedicalCode",
"code": "D057065",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750.032.099"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protease La",
"alternateName": "Protease La",
"url": "https://questionsmedicales.fr/mesh/D049070",
"about": {
"@type": "MedicalCondition",
"name": "Protease La",
"code": {
"@type": "MedicalCode",
"code": "D049070",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750.032.099.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Protease La",
"alternateName": "Protease La",
"url": "https://questionsmedicales.fr/mesh/D049070",
"about": {
"@type": "MedicalCondition",
"name": "Protease La",
"code": {
"@type": "MedicalCode",
"code": "D049070",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750.032.099.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "ATP-dependent endopeptidases",
"alternateName": "ATP-Dependent Endopeptidases",
"url": "https://questionsmedicales.fr/mesh/D057065",
"about": {
"@type": "MedicalCondition",
"name": "ATP-dependent endopeptidases",
"code": {
"@type": "MedicalCode",
"code": "D057065",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750.032.099"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protease La",
"alternateName": "Protease La",
"url": "https://questionsmedicales.fr/mesh/D049070",
"about": {
"@type": "MedicalCondition",
"name": "Protease La",
"code": {
"@type": "MedicalCode",
"code": "D049070",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750.032.099.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Protease La",
"alternateName": "Protease La",
"url": "https://questionsmedicales.fr/mesh/D049070",
"about": {
"@type": "MedicalCondition",
"name": "Protease La",
"code": {
"@type": "MedicalCode",
"code": "D049070",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750.032.099.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "N-Ethylmaleimide-sensitive factors",
"alternateName": "N-Ethylmaleimide-Sensitive Proteins",
"url": "https://questionsmedicales.fr/mesh/D052066",
"about": {
"@type": "MedicalCondition",
"name": "N-Ethylmaleimide-sensitive factors",
"code": {
"@type": "MedicalCode",
"code": "D052066",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750.375"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Protéines AAA",
"alternateName": "AAA Proteins",
"code": {
"@type": "MedicalCode",
"code": "D000074582",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Tarun M Kapoor",
"url": "https://questionsmedicales.fr/author/Tarun%20M%20Kapoor",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Chemistry and Cell Biology, The Rockefeller University, New York, NY, USA. kapoor@rockefeller.edu."
}
},
{
"@type": "Person",
"name": "Tommaso Cupido",
"url": "https://questionsmedicales.fr/author/Tommaso%20Cupido",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Chemistry and Cell Biology, The Rockefeller University, New York, NY, USA."
}
},
{
"@type": "Person",
"name": "Rudolf Pisa",
"url": "https://questionsmedicales.fr/author/Rudolf%20Pisa",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Chemistry and Cell Biology, The Rockefeller University, New York, NY, USA."
}
},
{
"@type": "Person",
"name": "James Shorter",
"url": "https://questionsmedicales.fr/author/James%20Shorter",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, U.S.A."
}
},
{
"@type": "Person",
"name": "Robert T Sauer",
"url": "https://questionsmedicales.fr/author/Robert%20T%20Sauer",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "vPIF-1 is an insulin-like antiferroptotic viral peptide.",
"datePublished": "2023-05-15",
"url": "https://questionsmedicales.fr/article/37186845",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1073/pnas.2300320120"
}
},
{
"@type": "ScholarlyArticle",
"name": "Apolipoprotein C-III is linked to the insulin resistance and beta-cell dysfunction that are present in rheumatoid arthritis.",
"datePublished": "2022-05-30",
"url": "https://questionsmedicales.fr/article/35637531",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13075-022-02822-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes.",
"datePublished": "2023-05-24",
"url": "https://questionsmedicales.fr/article/37226224",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12916-023-02900-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "High proinsulin:C-peptide ratio identifies individuals with stage 2 type 1 diabetes at high risk for progression to clinical diagnosis and responses to teplizumab treatment.",
"datePublished": "2023-09-04",
"url": "https://questionsmedicales.fr/article/37667106",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00125-023-06003-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of Manual Lymphatic Drainage on the Concentrations of Selected Adipokines, Cytokines, C-Reactive Protein and Parameters of Carbohydrate and Lipid Metabolism in Patients with Abnormal Body Mass Index: Focus on Markers of Obesity and Insulin Resistance.",
"datePublished": "2023-06-19",
"url": "https://questionsmedicales.fr/article/37373485",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241210338"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines de transport",
"item": "https://questionsmedicales.fr/mesh/D002352"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines AAA",
"item": "https://questionsmedicales.fr/mesh/D000074582"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéines AAA - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéines AAA",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-19",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protéines AAA",
"description": "Comment diagnostiquer une dysfonction des protéines AAA ?\nQuels tests sont utilisés pour évaluer les protéines AAA ?\nLes biopsies sont-elles utiles pour les protéines AAA ?\nQuels marqueurs biologiques sont associés aux protéines AAA ?\nLes imageries médicales aident-elles au diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D000074582?mesh_terms=C-Peptide&page=6#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protéines AAA",
"description": "Quels symptômes indiquent une anomalie des protéines AAA ?\nLes troubles cognitifs sont-ils liés aux protéines AAA ?\nY a-t-il des symptômes cutanés associés ?\nLes douleurs musculaires sont-elles fréquentes ?\nLes symptômes varient-ils selon les types de protéines AAA ?",
"url": "https://questionsmedicales.fr/mesh/D000074582?mesh_terms=C-Peptide&page=6#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protéines AAA",
"description": "Peut-on prévenir les dysfonctionnements des protéines AAA ?\nLes dépistages réguliers sont-ils utiles ?\nL'éducation génétique est-elle importante ?\nLes habitudes alimentaires influencent-elles la santé des protéines ?\nLe stress a-t-il un impact sur les protéines AAA ?",
"url": "https://questionsmedicales.fr/mesh/D000074582?mesh_terms=C-Peptide&page=6#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protéines AAA",
"description": "Quels traitements existent pour les dysfonctionnements des protéines AAA ?\nLa thérapie génique est-elle efficace ?\nDes médicaments spécifiques sont-ils disponibles ?\nLes approches nutritionnelles aident-elles ?\nLa physiothérapie est-elle recommandée ?",
"url": "https://questionsmedicales.fr/mesh/D000074582?mesh_terms=C-Peptide&page=6#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protéines AAA",
"description": "Quelles complications peuvent survenir avec les protéines AAA ?\nLes maladies cardiovasculaires sont-elles liées ?\nY a-t-il des risques de cancer associés ?\nLes troubles métaboliques sont-ils possibles ?\nLes complications sont-elles réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D000074582?mesh_terms=C-Peptide&page=6#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protéines AAA",
"description": "Quels sont les facteurs de risque pour les dysfonctionnements des protéines AAA ?\nL'hérédité joue-t-elle un rôle ?\nLe mode de vie influence-t-il le risque ?\nLes infections peuvent-elles affecter les protéines AAA ?\nLe vieillissement est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D000074582?mesh_terms=C-Peptide&page=6#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction des protéines AAA ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests génétiques et des analyses protéomiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les protéines AAA ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de fonction cellulaire et des dosages d'ATPase peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles utiles pour les protéines AAA ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les biopsies peuvent aider à évaluer l'expression des protéines AAA dans les tissus."
}
},
{
"@type": "Question",
"name": "Quels marqueurs biologiques sont associés aux protéines AAA ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs comme Hsp70 peuvent être utilisés pour évaluer l'activité des protéines AAA."
}
},
{
"@type": "Question",
"name": "Les imageries médicales aident-elles au diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie peut montrer des anomalies cellulaires, mais n'est pas spécifique aux protéines AAA."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une anomalie des protéines AAA ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes incluent la faiblesse musculaire, la fatigue et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les troubles cognitifs sont-ils liés aux protéines AAA ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies peuvent entraîner des troubles cognitifs et de la mémoire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies liées aux protéines AAA peuvent provoquer des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Les douleurs musculaires sont-elles fréquentes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs musculaires peuvent survenir en raison de dysfonctionnements des protéines."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les types de protéines AAA ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon le type de protéine AAA impliquée et la pathologie."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les dysfonctionnements des protéines AAA ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un mode de vie sain peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Les dépistages réguliers sont-ils utiles ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dépistages peuvent aider à identifier précocement les anomalies génétiques."
}
},
{
"@type": "Question",
"name": "L'éducation génétique est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation sur les maladies héréditaires peut aider à la prévention."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles la santé des protéines ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la santé cellulaire et protéique."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les protéines AAA ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affecter la fonction cellulaire et les protéines."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les dysfonctionnements des protéines AAA ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des thérapies géniques et des médicaments ciblant les voies cellulaires."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle efficace ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie génique montre des résultats prometteurs dans certaines pathologies liées."
}
},
{
"@type": "Question",
"name": "Des médicaments spécifiques sont-ils disponibles ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs de l'ATPase sont en cours d'étude pour traiter les dysfonctionnements."
}
},
{
"@type": "Question",
"name": "Les approches nutritionnelles aident-elles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une nutrition adéquate peut soutenir la fonction cellulaire, mais n'est pas un traitement direct."
}
},
{
"@type": "Question",
"name": "La physiothérapie est-elle recommandée ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la physiothérapie peut aider à gérer les symptômes musculaires et améliorer la fonction."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les protéines AAA ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des maladies neurodégénératives et des troubles musculaires."
}
},
{
"@type": "Question",
"name": "Les maladies cardiovasculaires sont-elles liées ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines dysfonctionnements des protéines AAA peuvent augmenter le risque cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de cancer associés ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies dans les protéines AAA peuvent être liées à certains types de cancer."
}
},
{
"@type": "Question",
"name": "Les troubles métaboliques sont-ils possibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dysfonctionnements peuvent entraîner des troubles métaboliques variés."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être irréversibles."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les dysfonctionnements des protéines AAA ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des prédispositions génétiques, l'âge et des facteurs environnementaux."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines mutations génétiques héréditaires augmentent le risque de dysfonction."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles affecter les protéines AAA ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales peuvent perturber la fonction des protéines AAA."
}
},
{
"@type": "Question",
"name": "Le vieillissement est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut affecter la fonction des protéines et augmenter les risques."
}
}
]
}
]
}
Iridoviridae, such as the lymphocystis disease virus-1 (LCDV-1) and other viruses, encode viral insulin-like peptides (VILPs) which are capable of triggering insulin receptors (IRs) and insulin-like g...
Insulin resistance and beta-cell dysfunction are manifestations of rheumatoid arthritis (RA). Apolipoprotein C-III (ApoC3) has been associated with such insulin resistance and beta-cell dysfunction in...
Three hundred thirty-eight non-diabetic patients with RA who had a glycemia lower than 110 mg/dl were recruited. Insulin, C-peptide, and ApoC3 were assessed. Insulin resistance and beta-cell function ...
ApoC3 was related to significant higher levels of circulating insulin (beta coef. 0.37 [95%CI 0.01-0.73] µU/ml, p = 0.044) and C-peptide (beta coef. 0.13 [95%CI 0.05-0.22] ng/ml, p = 0.003), and highe...
ApoC3, insulin resistance, and beta-cell dysfunction are independently associated in patients RA....
Type 1 diabetes (T1D) is a CD4...
This first-in-human, 24-week, double-blind phase 1b study evaluated the safety of three dosages of IMCY-0098 in adults diagnosed with T1D < 6 months before study start. Forty-one participants were ran...
Treatment with IMCY-0098 was well tolerated with no systemic reactions; a total of 315 adverse events (AEs) were reported in 40 patients (97.6%) and were related to study treatment in 29 patients (68....
Promising safety profile and preliminary clinical response data support the design of a phase 2 study of IMCY-0098 in patients with recent-onset T1D....
IMCY-T1D-001: ClinicalTrials.gov NCT03272269; EudraCT: 2016-003514-27; and IMCY-T1D-002: ClinicalTrials.gov NCT04190693; EudraCT: 2018-003728-35....
Tractable precision biomarkers to identify immunotherapy responders are lacking in type 1 diabetes. We hypothesised that proinsulin:C-peptide (PI:C) ratios, a readout of beta cell stress, could provid...
In this post hoc analysis, proinsulin and C-peptide levels were determined in baseline serum samples from 63 participants with stage 2 type 1 diabetes in the longitudinal TrialNet Teplizumab Preventio...
Elevated baseline PI:C was strongly associated with more rapid progression of diabetes in both the placebo and teplizumab treatment groups, but teplizumab abrogated the impact of high pre-treatment PI...
High pre-treatment PI:C identified individuals with stage 2 type 1 diabetes who were exhibiting rapid progression to stage 3 disease and who displayed benefit from teplizumab treatment. These data sug...
The aim of the study was to assess the impact of manual lymphatic drainage (MLD) on the parameters of carbohydrate metabolism, lipid metabolism and the level of selected adipokines and cytokines in pe...
Insulin-like peptides are a group of hormones crucial for regulating metabolism, growth, and development in animals. Invertebrates, such as C. elegans, have been instrumental in understanding the mole...
Spontaneous aggregation of amyloid beta (Aβ) leads to the formation of neurotoxic senile plaque considered as the most crucial event in Alzheimer's disease (AD) progression. Inhibition or disruption o...
The site-selective modification of peptides and proteins facilitates the preparation of targeted therapeutic agents and tools to interrogate biochemical pathways. Among the numerous bioconjugation tec...
Drawing inspiration from the initiating amino acid modification in biosynthetic peptides, we have successfully demonstrated a biomimetic mechanism for N-to-C terminal extension in prebiotic peptide sy...
The harmonization of laboratory biomarkers is pivotal in ensuring consistent and reliable diagnostic outcomes across different clinical settings. This systematic review examines the harmonization of C...